Does TAPENTADOL Cause Urinary retention? 65 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 65 reports of Urinary retention have been filed in association with TAPENTADOL (Nucynta). This represents 0.2% of all adverse event reports for TAPENTADOL.
65
Reports of Urinary retention with TAPENTADOL
0.2%
of all TAPENTADOL reports
1
Deaths
16
Hospitalizations
How Dangerous Is Urinary retention From TAPENTADOL?
Of the 65 reports, 1 (1.5%) resulted in death, 16 (24.6%) required hospitalization, and 1 (1.5%) were considered life-threatening.
Is Urinary retention Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TAPENTADOL. However, 65 reports have been filed with the FAERS database.
What Other Side Effects Does TAPENTADOL Cause?
Death (11,560)
Toxicity to various agents (9,617)
Overdose (5,843)
Drug abuse (1,566)
Drug dependence (1,019)
Drug withdrawal syndrome neonatal (945)
Accidental overdose (693)
Drug ineffective (633)
Pain (436)
Nausea (434)
What Other Drugs Cause Urinary retention?
MIRABEGRON (706)
QUETIAPINE (617)
TAMSULOSIN (475)
ADALIMUMAB (452)
MORPHINE (407)
OLANZAPINE (405)
SERTRALINE (380)
PREGABALIN (376)
RISPERIDONE (375)
DULOXETINE (362)
Which TAPENTADOL Alternatives Have Lower Urinary retention Risk?
TAPENTADOL vs TAPINAROF
TAPENTADOL vs TARCEVA
TAPENTADOL vs TARLATAMAB
TAPENTADOL vs TARLATAMAB-DLLE
TAPENTADOL vs TASIGNA